These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 7940892)

  • 1. How do cells recover from inhibition by cyclosporine?
    Batiuk TD; Pazderka F; Halloran PF
    Transplant Proc; 1994 Oct; 26(5):2831-2. PubMed ID: 7940892
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine-treated renal transplant patients have only partial inhibition of calcineurin phosphatase activity.
    Batiuk TD; Pazderka F; Halloran PF
    Transplant Proc; 1995 Feb; 27(1):840-1. PubMed ID: 7879200
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine inhibition of calcineurin activity in human leukocytes in vivo is rapidly reversible.
    Batiuk TD; Pazderka F; Enns J; DeCastro L; Halloran PF
    J Clin Invest; 1995 Sep; 96(3):1254-60. PubMed ID: 7657799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the dose-response curve for the effects of cyclosporine on calcineurin and cytokine induction in vivo?
    Batiuk TD; Yatscoff RW; Halloran PF
    Transplant Proc; 1994 Oct; 26(5):2835-6. PubMed ID: 7940893
    [No Abstract]   [Full Text] [Related]  

  • 5. Recovery of blood mononuclear cell calcineurin activity segregates two populations of renal transplant patients with different sensitivities to cyclosporine inhibition.
    Piccinini G; Gaspari F; Signorini O; Remuzzi G; Perico N
    Transplantation; 1996 May; 61(10):1526-31. PubMed ID: 8633383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin protein phosphatase activity in peripheral blood lymphocytes.
    Rusnak F; Beressi AH; Haddy A; Tefferi A
    Bone Marrow Transplant; 1996 Mar; 17(3):309-13. PubMed ID: 8704679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin mutants render T lymphocytes resistant to cyclosporin A.
    Zhu D; Cardenas ME; Heitman J
    Mol Pharmacol; 1996 Sep; 50(3):506-11. PubMed ID: 8794888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients.
    Batiuk TD; Pazderka F; Halloran PF
    Transplantation; 1995 May; 59(10):1400-4. PubMed ID: 7770925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin: not just a simple protein phosphatase.
    Guerini D
    Biochem Biophys Res Commun; 1997 Jun; 235(2):271-5. PubMed ID: 9199180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin-mediated ET-1 gene regulation involves CaM kinases and calcineurin in human endothelial cells.
    Marsen TA; Simonson MS; Dunn MJ
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S1-4. PubMed ID: 8587330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin activates transcription from the GM-CSF promoter in synergy with either protein kinase C or NF-kappa B/AP-1 in T cells.
    Tsuboi A; Muramatsu M; Tsutsumi A; Arai K; Arai N
    Biochem Biophys Res Commun; 1994 Mar; 199(2):1064-72. PubMed ID: 8135780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanisms of action of cyclosporin A : implications for its side effects.
    Takahashi N
    J Toxicol Sci; 1995 Sep; 20(4):480-2. PubMed ID: 8531247
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcineurin inhibitors, FK506 and cyclosporin A, suppress the NMDA receptor-mediated potentials and LTP, but not depotentiation in the rat hippocampus.
    Lu YF; Tomizawa K; Moriwaki A; Hayashi Y; Tokuda M; Itano T; Hatase O; Matsui H
    Brain Res; 1996 Aug; 729(1):142-6. PubMed ID: 8874888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of NF-AT signal transduction events by a dominant-negative form of calcineurin.
    Muramatsu T; Kincaid RL
    Biochem Biophys Res Commun; 1996 Jan; 218(2):466-72. PubMed ID: 8561779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concepts of the mechanisms of action of cyclosporin in psoriasis. A review with guidelines on therapy].
    Mrowietz U
    Hautarzt; 1993 Jun; 44(6):353-60. PubMed ID: 8392987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrolysis of trifluoroethyl phosphate as evidence that the serine and tyrosine phosphatase activities of calcineurin share the same specificity determinant.
    Martin BL; Graves DJ
    Biochem Biophys Res Commun; 1993 Jul; 194(1):150-6. PubMed ID: 8392834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CaMKII/calcineurin switch controls the direction of Ca(2+)-dependent growth cone guidance.
    Wen Z; Guirland C; Ming GL; Zheng JQ
    Neuron; 2004 Sep; 43(6):835-46. PubMed ID: 15363394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESR study on calcineurin.
    Wei Q; Xiao F; Lu J; Zhou J
    Sci China B; 1995 Sep; 38(9):1117-22. PubMed ID: 8554679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcineurin-mediated adaptation to salt stress in yeast].
    Miyakawa T; Nakamura T; Hirata D
    Tanpakushitsu Kakusan Koso; 1994 Mar; 39(4):420-8. PubMed ID: 8165287
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence that calcineurin is rate-limiting for primary human lymphocyte activation.
    Batiuk TD; Kung L; Halloran PF
    J Clin Invest; 1997 Oct; 100(7):1894-901. PubMed ID: 9312192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.